Natera, Inc. Investing Cash Flow increased by 55.1% to -$32.14M in Q1 2026 compared to the prior quarter. Year-over-year, this metric declined by 91.1%, from -$16.82M to -$32.14M. Over 3 years (FY 2022 to FY 2025), Investing Cash Flow shows a downward trend with a -26.3% CAGR.
A negative value typically signals investment in future growth, while a positive value may indicate divestment or the maturity of a large investment portfolio.
This metric is the net total of all cash inflows and outflows related to investing activities, including capital expendi...
Most mature healthcare companies maintain a negative net investing cash flow due to ongoing R&D and infrastructure investment.
net_cash_from_investing| Q2 '21 | Q3 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $59.97M | -$431.41M | $207.03M | $34.79M | $66.60M | $21.92M | $15.87M | $47.19M | $81.29M | $24.15M | $138.26M | -$32.05M | $42.54M | $0.00 | -$16.82M | -$23.90M | -$19.91M | -$71.59M | -$32.14M |
| QoQ Change | — | -819.4% | +148.0% | -83.2% | +91.4% | -67.1% | -27.6% | +197.4% | +72.3% | -70.3% | +472.6% | -123.2% | +232.7% | -100.0% | — | -42.1% | +16.7% | -259.7% | +55.1% |
| YoY Change | — | — | — | -42.0% | +115.4% | — | -92.3% | +35.6% | +22.1% | +10.2% | +771.2% | -167.9% | -47.7% | -100.0% | -112.2% | +25.4% | -146.8% | — | -91.1% |